About BioNexGen

The project BioNexGen is a collaborative research project which has started in September 2010 and will last until February 2014.

It is co-financed by the European Commission with a funding of 3.4 million Euros.

The consortium consists of 11 partners from 8 countries including 4 countries of the Middle East and North Africa (Germany, Italy, United Kingdom, Greece, Turkey, Syria, Egypt and Tunisia).

Principle of BioNexGen

Membrane bioreactor (MBR) technology is regarded as a key element of advanced wastewater reclamation and reuse schemes and can considerably contribute to sustainable water management. MBR technology is used for wastewater treatment and reuse in municipal, agricultural and a variety of industrial sectors in Europe and MENA.

The objective of the BioNexGen project is therefore to develop a new class of functional low fouling membranes for membrane bioreactor technology with high and constant water flux and high rejection of organic pollutants with low molecular weight.

The consortium will develop a novel single step NF MBR operated with low energy consumption.

Small footprint, flexible design, and automated operation make it ideal for localized, decentralized wastewater treatment and recycling in the European and MENA countries.

Successful delivery will have a major impact on the competitiveness of the SME partners in the project and the European and MENA MBR market. Furthermore it will significantly contribute to scientific and technological cooperation between European and MENA countries in the provision of safe water.

BioNexGen is co-financed by the European Commission under the 7th Framework Programme